Opin vísindi

Fletta eftir höfundi "Clayton, Peter E."

Fletta eftir höfundi "Clayton, Peter E."

Röðun: Raða: Niðurstöður:

  • Boguszewski, Margaret C.S.; Boguszewski, Cesar L.; Chemaililly, Wassim; Cohen, Laurie E.; Gebauer, Judith; Higham, Claire; Hoffman, Andrew R.; Polak, Michel; Yuen, Kevin C.J.; Alos, Nathalie; Antal, Zoltan; Bidlingmaier, Martin; Biller, Beverley M.K.; Brabant, George; Choong, Catherine S.Y.; Cianfarani, Stefano; Clayton, Peter E.; Coutant, Regis; Cardoso-Demartini, Adriane A.; Fernandez, Alberto; Grimberg, Adda; Guðmundsson, Kolbeinn; Guevara-Aguirre, Jaime; K Y Ho, Ken; Horikawa, Reiko; Isidori, Andrea M.; Otto Lunde Jørgensen, Jens; Kamenicky, Peter; Karavitaki, Niki; Kopchick, John J.; Lodish, Maya; Luo, Xiaoping; McCormack, Ann I.; Meacham, Lillian; Melmed, Shlomo; Moab, Sogol Mostoufi; Müller, Hermann L.; Neggers, Sebastian J.C.M.M.; Aguiar Oliveira, Manoel H.; Ozono, Keiichi; Pennisi, Patricia A.; Popovic, Vera; Radovick, Sally; Savendahl, Lars; Touraine, Philippe; van Santen, Hanneke M.; Johannsson, Gudmundur (2022-06)
    Growth hormone (GH) has been used for over 35 years, and its safety and efficacy has been studied extensively. Experimental studies showing the permissive role of GH/insulin-like growth factor 1 (IGF-I) in carcinogenesis have raised concerns regarding ...